KTI-018

N/A

Report date: 2024/11/18 13:07:05

Base Information

Drug NameKTI-018
Drug Alias NameKTI-018
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionActivin receptor type-1 inhibitors
TargetsActivin receptor type-1
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKeros Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKeros Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAnemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A